ClinicalTrials.gov
ClinicalTrials.gov Menu

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? (GREAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01845259
Recruitment Status : Unknown
Verified May 2016 by Anders Fink-Jensen, MD, DMSci, Psychiatric Centre Rigshospitalet.
Recruitment status was:  Active, not recruiting
First Posted : May 3, 2013
Last Update Posted : May 5, 2016
Sponsor:
Collaborators:
University Hospital, Gentofte, Copenhagen
University of Cambridge
Information provided by (Responsible Party):
Anders Fink-Jensen, MD, DMSci, Psychiatric Centre Rigshospitalet

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : March 2016
  Estimated Study Completion Date : March 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):